APOE and dementia: The results of past studies looking at duloxetine (a serotonin-noradrenaline reuptake inhibitor (SNRI)) and NDDs have shown inconclusive results.19,20 In our study, it was still associated with dementia, even after adjusting for risk conditions and APOE-ε4 status.